[go: up one dir, main page]

RU2019128667A3 - - Google Patents

Download PDF

Info

Publication number
RU2019128667A3
RU2019128667A3 RU2019128667A RU2019128667A RU2019128667A3 RU 2019128667 A3 RU2019128667 A3 RU 2019128667A3 RU 2019128667 A RU2019128667 A RU 2019128667A RU 2019128667 A RU2019128667 A RU 2019128667A RU 2019128667 A3 RU2019128667 A3 RU 2019128667A3
Authority
RU
Russia
Application number
RU2019128667A
Other languages
Russian (ru)
Other versions
RU2019128667A (en
RU2745265C2 (en
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Priority to RU2019128667A priority Critical patent/RU2745265C2/en
Priority to EA202090135A priority patent/EA038170B1/en
Priority to UAA202000680A priority patent/UA125151C2/en
Priority to PCT/RU2020/050219 priority patent/WO2021049980A1/en
Publication of RU2019128667A publication Critical patent/RU2019128667A/en
Publication of RU2019128667A3 publication Critical patent/RU2019128667A3/ru
Application granted granted Critical
Publication of RU2745265C2 publication Critical patent/RU2745265C2/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/41641,3-Diazoles
    • A61K31/4172Imidazole-alkanecarboxylic acids, e.g. histidine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/41641,3-Diazoles
    • A61K31/41781,3-Diazoles not condensed 1,3-diazoles and containing further heterocyclic rings, e.g. pilocarpine, nitrofurantoin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/16Antivirals for RNA viruses for influenza or rhinoviruses
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
RU2019128667A 2019-09-12 2019-09-12 Novel 2-(imidazol-4-yl)-ethanamide of pentandioic-1,5 acid compositions for treating and preventing viral diseases RU2745265C2 (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
RU2019128667A RU2745265C2 (en) 2019-09-12 2019-09-12 Novel 2-(imidazol-4-yl)-ethanamide of pentandioic-1,5 acid compositions for treating and preventing viral diseases
EA202090135A EA038170B1 (en) 2019-09-12 2020-01-23 Pentandioic-1,5 acid 2-(imidazol-4-yl)ethanamide formulations for treating and preventing viral diseases
UAA202000680A UA125151C2 (en) 2019-09-12 2020-02-04 Novel 2-(imidazol-4-yl)-ethanamide pentanedioic-1,5 acid compositions for treatment and prevention of viral diseases
PCT/RU2020/050219 WO2021049980A1 (en) 2019-09-12 2020-09-10 Novel compositions for treatment and prophylaxis of viral diseases

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
RU2019128667A RU2745265C2 (en) 2019-09-12 2019-09-12 Novel 2-(imidazol-4-yl)-ethanamide of pentandioic-1,5 acid compositions for treating and preventing viral diseases

Related Child Applications (2)

Application Number Title Priority Date Filing Date
RU2020111926A Division RU2782532C2 (en) 2020-03-24 New formulations of 2-(imidazole-4-yl)-ethanamide pentanedioic-1,5 acid for the treatment and prevention of viral diseases
RU2020111932A Division RU2791902C2 (en) 2020-03-24 Novel formulations of 2-(imidazol-4-yl)-ethanamide of pentanedioic acid for treatment and prevention of viral diseases

Publications (3)

Publication Number Publication Date
RU2019128667A RU2019128667A (en) 2021-03-12
RU2019128667A3 true RU2019128667A3 (en) 2021-03-12
RU2745265C2 RU2745265C2 (en) 2021-03-22

Family

ID=74873846

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2019128667A RU2745265C2 (en) 2019-09-12 2019-09-12 Novel 2-(imidazol-4-yl)-ethanamide of pentandioic-1,5 acid compositions for treating and preventing viral diseases

Country Status (3)

Country Link
EA (1) EA038170B1 (en)
RU (1) RU2745265C2 (en)
UA (1) UA125151C2 (en)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS4920974B1 (en) * 1970-06-01 1974-05-29
RU2141483C1 (en) * 1997-07-04 1999-11-20 Небольсин Владимир Евгеньевич Peptide derivatives or their pharmaceutically acceptable salts, method of their synthesis, use and pharmaceutical composition
RU2665688C2 (en) * 2013-04-12 2018-09-04 Общество С Ограниченной Ответственностью "Фарминтерпрайсез" Dicarboxylic acid bisamide derivatives, their application, the pharmaceutical composition on their basis, methods for their production
RU2679636C1 (en) * 2018-10-29 2019-02-12 Общество С Ограниченной Ответственностью "Фарминтерпрайсез" New method of the n,n'-bis[2-(1h-imidazol-4-yl)ethyl]malonamide obtaining

Also Published As

Publication number Publication date
EA202090135A1 (en) 2021-03-31
EA038170B1 (en) 2021-07-19
RU2019128667A (en) 2021-03-12
UA125151C2 (en) 2022-01-19
RU2745265C2 (en) 2021-03-22

Similar Documents

Publication Publication Date Title
BR112019017762A2 (en)
BR112021017339A2 (en)
BR112021018450A2 (en)
BR112021017637A2 (en)
BR112021017892A2 (en)
BR112021017782A2 (en)
BR112021017939A2 (en)
BR112019016141A2 (en)
BR112021017738A2 (en)
BR112021008711A2 (en)
BR112021016821A2 (en)
BR112021018452A2 (en)
BR112021017703A2 (en)
BR112021017728A2 (en)
BR112021016996A2 (en)
AU2020104490A5 (en)
BR112021013944A2 (en)
BR112019016142A2 (en)
BR112019016138A2 (en)
BR112021018250A2 (en)
BR112021017234A2 (en)
BR112021018168A2 (en)
BR112021017083A2 (en)
BR112021017732A2 (en)
BR112021015080A2 (en)

Legal Events

Date Code Title Description
PD4A Correction of name of patent owner
QB4A Licence on use of patent

Free format text: LICENCE FORMERLY AGREED ON 20210722

Effective date: 20210722